Randomization was conducted using an interactive web response system, assigning participants in a 6:1 ratio to one of several treatment arms: once-weekly subcutaneous Cagrilintide administered in doses of 0.3, 0.6, 1.2, 2.4, or 4.5 mg, once-daily liraglutide 3.0 mg, or a volume-matched placebo
A Simple Treatment The only way for PA patients to absorb B12 is through injections straight to the bloodstream
Lazaridis I, Tzortzi O, Weglage M, Mrtin A, Xuan Y, Parent M, et al
Oxidized pullulan exhibits potent antibacterial activity against S
Liquid chromatography separates compounds in a sample before mass spectrometry analysis
For men struggling with low testosterone, obesity, and sexual dysfunction, this could open the door to more effective, sustainable treatment options